DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹82.68 | ₹60.38 | ₹68.83 | ₹111.53 | ₹74.75 |
What is the latest Earnings Per Share (EPS) of DIVIS LABORATORIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹82.68 |
| Mar2024 | ₹60.38 |
| Mar2023 | ₹68.83 |
| Mar2022 | ₹111.53 |
| Mar2021 | ₹74.75 |
How is Earnings Per Share (EPS) of DIVIS LABORATORIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹82.68 | 36.93 | |
| Mar2024 | ₹60.38 | -12.28 | |
| Mar2023 | ₹68.83 | -38.29 | |
| Mar2022 | ₹111.53 | 49.20 | |
| Mar2021 | ₹74.75 | - | |
Compare Earnings Per Share (EPS) of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹170,814.7 Cr | -3.1% | 0.1% | 11.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,037.0 Cr | -3% | -3.6% | -4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,332.0 Cr | -3.7% | 4% | 18.8% | Stock Analytics | |
| CIPLA | ₹116,933.0 Cr | -1.3% | -4.6% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,350.2 Cr | -4.2% | -7% | -11.4% | Stock Analytics | |
| MANKIND PHARMA | ₹91,355.8 Cr | -4.3% | 1.5% | -21.3% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -3.1% |
0.1% |
11.4% |
| SENSEX | -1.7% |
-1.4% |
7% |
You may also like the below Video Courses